Showing results (1-10 of 499) with videos related to
Sort By:
Pageof 50
Pharmacological Reviews|August 20, 2004
Opioids as modulators of cell death and survival--unraveling mechanisms and revealing new indicationsIrmgard Tegeder, Gerd GeisslingerNaunyn-Schmiedeberg'S Archives of Pharmacology|April 6, 2006
Cardiovascular risk with cyclooxygenase inhibitors: general problem with substance specific differences?Irmgard Tegeder, Gerd GeisslingerInternational Journal of Molecular Sciences|September 21, 2017
Monoclonal Antibodies in Preclinical EAE Models of Multiple Sclerosis: A Systematic ReviewKatja Schmitz, Gerd Geisslinger, Irmgard TegederTrends in Neurosciences|May 6, 2009
No NO, no pain? The role of nitric oxide and cGMP in spinal pain processingAchim Schmidtko, Irmgard Tegeder, Gerd GeisslingerPharmacology & Therapeutics|July 21, 2009
Genetic modulation of the pharmacological treatment of painJörn Lötsch, Gerd Geisslinger, Irmgard TegederBritish Journal of Clinical Pharmacology|November 26, 2002
Validation of a new fluorogenic real-time PCR assay for detection of CYP2C9 allelic variants and CYP2C9 allelic distribution in a German populationMaria Burian, Sabine Grösch, Irmgard Tegeder, et al.Pharmacological Reviews|March 26, 2011
SNO-ing at the nociceptive synapse?Irmgard Tegeder, Reynir Scheving, Ilka Wittig, et al.Clinical Pharmacokinetics|February 5, 2002
Drug interactions with patient-controlled analgesiaJorn Lotsch, Carsten Skarke, Irmgard Tegeder, et al.Nitric Oxide : Biology and Chemistry|March 7, 2003
Inhibition of cyclic guanosine 5'-monophosphate-dependent protein kinase I (PKG-I) in lumbar spinal cord reduces formalin-induced hyperalgesia and PKG upregulationAchim Schmidtko, Peter Ruth, Gerd Geisslinger, et al.Clinical Pharmacology and Therapeutics|August 2, 2003
Peripheral and central antihyperalgesic effects of diclofenac in a model of human inflammatory painMaria Burian, Irmgard Tegeder, Maic Seegel, et al.Pageof 50